Treatment with dupilumab led to significant improvements in lung function by 16 weeks and up to 24 weeks in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma plus clinical features of COPD.
In patients with idiopathic pulmonary fibrosis, treatment with pirfenidone was associated with a lower risk of mortality and acute respiratory-related hospitalizations than treatment with nintedanib.
Treatment with LIQ861, an inhaled dry-powder form of treprostinil, was associated with significant improvements in several clinical and quality of life measures in patients with pulmonary arterial hypertension.
Treatment with steroids within a 48-hour period after intubation in the intensive care unit was not associated with the development of acute respiratory distress syndrome.
Nebulized ensifentrine, when added to tiotropium, produced clinically meaningful and significant improvements in lung function and quality of life in patients with COPD.
Patients with COPD who received a metered dose inhaler containing budesonide, glycopyrrolate, and formoterol fumarate showed lung function improvements through 52 weeks.
Subclinical bacteria in the home environment likely influence the airway microbiome and contribute to poor asthma control in patients with refractory asthma.
Patients with severe eosinophilic asthma who received benralizumab experienced significant improvements in several health-related quality of life measures.
There are significant differences in perceptions of prevalence, risk factors, and the management of RA-associated interstitial lung disease between rheumatologists and pulmonologists.
Electronic cigarette use is associated with lifetime asthma in US adolescents, and may become more damaging when combined with marijuana or cigarette smoking.
Young adults with asthma experienced improved clinical outcomes after undergoing virtual care, known as a multi-level EMR-integrated smartphone-telemedicine program.
Compared with white patients, black patients with screen-detected cancers had a lower calculated lung cancer risk, despite having a significantly higher mean 6-year lung cancer risk.
Prenatal and early life exposure to household air pollution may affect the development of lung function and lead to an increase in airway resistance in children.
In patients with COPD, treatment with single-inhaler fluticasone furoate/umeclidinium/vilanterol resulted in more health status improvements and greater lung function benefit compared with multiple-inhaler triple therapy.
